当前位置:首页 - 行情中心 - 荃银高科(300087) - 财务分析 - 利润表

荃银高科

(300087)

  

流通市值:69.79亿  总市值:73.80亿
流通股本:8.96亿   总股本:9.47亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入4,102,895,157.951,553,898,833.471,079,920,148.65617,457,763.96
营业收入4,102,895,157.951,553,898,833.471,079,920,148.65617,457,763.96
二、营业总成本3,751,320,177.321,570,192,767.371,033,946,295.99581,766,004.85
营业成本2,998,872,026.291,203,535,931.62812,497,733.78476,516,617.24
税金及附加9,089,167.125,306,685.613,535,273.831,759,165.25
销售费用361,934,555.64171,790,282.25103,712,222.8345,792,088.74
管理费用226,094,183.83123,500,899.9874,554,349.4633,495,950.13
研发费用126,116,209.3851,197,946.5532,053,085.6216,579,534.2
财务费用29,214,035.0614,861,021.367,593,630.477,622,649.29
其中:利息费用38,176,669.7824,635,569.2215,834,333.628,065,760.85
其中:利息收入12,499,801.6510,644,272.78,564,637.173,403,589.72
加:投资收益5,734,698.44,714,306.533,878,574.3462,741.25
资产处置收益305,212.72346,714.55637,429.41-23,678.36
资产减值损失(新)-19,673,524.33-623,079.22-619,249.22-
信用减值损失(新)-30,081,736.91-8,757,093.26-316,743.57-5,026,310.78
其他收益47,097,600.7931,080,402.6115,734,090.797,902,012.48
营业利润平衡项目0000
四、营业利润354,957,231.310,467,317.3165,287,954.4138,606,523.7
加:营业外收入17,858,248.89717,327.79394,925.8889,668.21
减:营业外支出10,856,592.522,096,163.871,891,740.481,509,350.22
利润总额平衡项目0000
五、利润总额361,958,887.679,088,481.2363,791,139.8137,186,841.69
减:所得税费用-1,786,603.42-220,403.01-283,888.31-401,707.42
六、净利润363,745,491.099,308,884.2464,075,028.1237,588,549.11
持续经营净利润363,745,491.099,308,884.2464,075,028.1237,588,549.11
归属于母公司股东的净利润273,862,389.9410,636,882.4739,420,033.9331,317,074.01
少数股东损益89,883,101.15-1,327,998.2324,654,994.196,271,475.1
(一)基本每股收益0.290.010.040.05
(二)稀释每股收益0.290.010.040.05
八、其他综合收益3,956,186.616,319,468.614,138,507.61-145,276.51
归属于母公司股东的其他综合收益3,956,186.616,319,468.614,138,507.61-145,276.51
九、综合收益总额367,701,677.715,628,352.8568,213,535.7337,443,272.6
归属于母公司股东的综合收益总额277,818,576.5516,956,351.0843,558,541.5431,171,797.5
归属于少数股东的综合收益总额89,883,101.15-1,327,998.2324,654,994.196,271,475.1
公告日期2024-03-232023-10-272023-08-262023-04-25
审计意见(境内)标准无保留意见
TOP↑